Should I Buy Regulus Therapeutics Inc (RGLS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on...
Posts Tagged ‘NASDAQ:RGLS’
Hedge Funds Are Dumping Regulus Therapeutics Inc (RGLS)
How do we determine whether Regulus Therapeutics Inc (NASDAQ:RGLS) makes for a good investment at the moment? We analyze the sentiment of a select group...
13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
13G Filing: Broadfin Capital and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
13G Filing: EcoR1 Capital and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 7 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Insider Buying at Regulus Therapeutics Inc (RGLS) Sends Stock Soaring
What: Regulus Therapeutics Inc (NASDAQ:RGLS) shares have jumped $0.30 per share, or 24%, to $1.55 in after hours on Thursday. Traders have bid up shares...
How Regulus Therapeutics Inc (RGLS) Stacks Up Against Its Peers
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of...
Why Are These Stocks Deep in Red Today?
Although the three major indexes have each opened 1% higher, a number of stocks have lost ground in Tuesday intraday trading. Among the losers today are...
What’s Going On With These 5 Trending Stocks?
U.S stocks are trading down ever so slightly on this fine Friday afternoon. Even though oil prices are plummeting ahead of the Doha oil producers’...
Is Regulus Therapeutics Inc (RGLS) Going to Burn These Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than...
Trellus Management’s Top Biotech Stock Picks For Q4
Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994. The fund manages client focused equity portfolios and...
RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech
The biotechnology industry is up by more than 50% over the last year, but these towering returns don’t come without great risk and volatility. However...
Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital’s Top New Biotech Picks
Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the...
Alkermes Plc (ALKS), Quest Diagnostics Inc (DGX): This Week in Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
This Metric Says You Are Smart to Sell Star Scientific, Inc. (STSI)
Star Scientific, Inc. (NASDAQ:STSI) was in 4 hedge funds’ portfolio at the end of March. STSI investors should be aware of a decrease in support...
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS), Regulus Therapeutics Inc (RGLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on...
The Coca-Cola Company (KO), Tesla Motors Inc (TSLA) Among Stocks to Sell Near 52-Week Highs
Commodities may be in the midst of a nasty sell-off, and worries about Cyprus’ financial ripples continue to persist, yet 2,300 of 4,800 companies...
